BALATON,
Minn., April 30, 2024 /PRNewswire/ -- Iterro,
Inc. (previously The trū Shrimp Companies, Inc.), a Minnesota-based producer of medical-grade
chitosan, restaurant-quality shrimp, and premium pet food
ingredients, has announced the addition of Dr. Kevin Croston to its Board of Directors,
effective May 1, 2024. Dr. Croston
joins the Company's existing six-member Board of Directors,
representing the Company's lead shareholders.
"We're thrilled to welcome Dr. Croston to our Board of Director
team," said Brian Knochenmus,
Chairman of the Board and CEO at Iterro. "Dr. Croston's extensive
knowledge in medical trauma care and his entrepreneurial spirit
will make him a great addition to our board. He will bring a needed
depth and breadth of medical experience into our boardroom."
Dr. Croston spent the last 31 years of his career at North
Memorial Health in Robbinsdale,
MN. He most recently held the position of Chief Executive
Officer for over nine years. Prior to that, he was the Chief
Medical Officer, President of Physician Services, and held the
position of Surgical Director of Trauma at North Memorial Health.
He is currently an Executive Committee Member and Chairman of the
Trauma Center Association of America. Dr. Croston earned his Doctor
of Medicine and Bachelor of Science in Biology (cum laude) degrees
from the University of South Dakota in
Vermillion, SD. He completed his general surgery residency
at Hennepin County Medical Center in Minneapolis, MN and is a Fellow in the
American College of Surgeons.
This announcement comes as Iterro continues to raise the capital
required to build its first large-scale shrimp production facility,
Madison Bay Harbor, in Madison, SD. "We are no longer 'just a shrimp
company' and continue to learn how amazing our medical application
chitosan is each day," said Knochenmus. "We are taking major steps
forward, with our continued focus on breaking ground in
Madison. Adding the experience and
expertise of Dr. Croston to our Board supports our focus on
chitosan and the future growth of this Company."
"I was honored by the invitation to serve on the Board of
Directors at Iterro. I was able to tour Balaton Bay Reef, the
Innovation Center, and was impressed by the team and the
facilities. I am most amazed by trū Chitosan as there is nothing in
the world like it. I am excited to be a part of identifying
applications for trū Chitosan in the medical and pharmaceutical
segments," said Dr. Croston.
About Iterro, Inc.
Iterro (pronounced "ih-TEHR-oh") is a global leader in the
sustainable production of pharmaceutical and medical device
applications chitosan, restaurant-quality shrimp, and high-protein
pet food ingredients. Powered by their revolutionary Tidal Basin®
collective technologies, Iterro uses vertical indoor farming
techniques to cultivate and harvest shrimp and its molted shell
tissue with unprecedented productivity, 100% of which is
commercialized across its three industry verticals (trū® Chitosan,
trū® Shrimp, and trū® Protein).
Media Inquiries:
Jennifer Graven
info@iterrolife.com
330 3rd Street
Balaton, MN 56115 USA
www.iterrolife.com
View original
content:https://www.prnewswire.com/news-releases/iterro-announces-new-appointment-to-board-of-directors-302130632.html
SOURCE Iterro